Physician profile
Ryan Mark Stephenson
NPI 1760800353
$1,562.98
in general payments reported to CMS, 2019-2025
19 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $382 · 2021: $173 · 2022: $160 · 2023: $307 · 2024: $29.49 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.29 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $392.69 | 2020-2023 | Tula, Halo |
| Stryker Corporation | $249.96 | 2019 | |
| Genzyme Corporation | $196.42 | 2022-2025 | |
| Optinose US, INC. | $192.36 | 2020-2023 | |
| Intersect Ent, INC. | $147.03 | 2019 | |
| Amgen INC. | $60.25 | 2022-2025 | Tavneos |
| Regeneron Healthcare Solutions, INC. | $58.49 | 2022-2023 | Dupixent |
| Inspire Medical Systems, INC. | $33.08 | 2025 | Inspire |
| Amneal Pharmaceuticals LLC | $29.75 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $29.61 | 2025 | Tezspire |
| Lilly USA, LLC | $26.33 | 2022 | |
| Merck Sharp & Dohme LLC | $25.44 | 2021 | |
| Ibsa Pharma INC. | $23.53 | 2021 | |
| Aroa Biosurgery Incorporated | $21.09 | 2022 | |
| Aerin Medical INC. | $17.21 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $16.17 | 2021 | |
| Horizon Therapeutics Plc | $16.08 | 2021 | |
| Glaxosmithkline, LLC. | $15.05 | 2022 | |
| Turn-Key Medical, INC. | $12.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Stephenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.